-1:

Hongguang Deng1, Yu Han1, Liang Liu1

  • 1Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.

PubMed
概括

骨髓性白血病-1 (Mcl-1) 是癌症中高度表达的亡的关键调节者. 向Mcl-1为癌症治疗提供了一个有希望的策略,尽管需要仔细考虑心脏毒性.